Skip to content

Aquestive Therapeutics, Inc. AQST Other Non-Current Assets

Other Non-Current Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$26M-33.3%
AMP
Amphastar PharmaceuticalsAMPH
$33.48M+45.6%
Regenxbio logo
RegenxbioRGNX
$5.51M+84.6%
Viatris logo
ViatrisVTRS
AptarGroup logo
AptarGroupATR
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%
Debt / equity-1.9×
Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s other non-current assets?
Aquestive Therapeutics, Inc. (AQST) reported other non-current assets of $2.64M in Q1 2026.
How has Aquestive Therapeutics, Inc.'s other non-current assets changed year-over-year?
Aquestive Therapeutics, Inc.'s other non-current assets decreased by 37.5% year-over-year, from $4.22M to $2.64M.
What is the long-term trend for Aquestive Therapeutics, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s other non-current assets has grown at a -19.5% compound annual growth rate (CAGR), from $7.84M to $2.64M.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.